PARP1 and glioblastoma: The radiosensitizing effects of PARP1 and HSP90 inhibition on GBM cells have been shown by many groups including ours [18, 37–39], thus providing principal validating evidence for our correlation approach and confirming the functional involvement of the potential target genes identified.